EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Schizophrenia Patients Discharged on Clozapine Plus Long-Acting Injectable Antipsychotics From a Public Psychiatric Hospital in Taiwan, 2006–2021

Ta-Chun Lin, Ching-Hua Lin

International Journal of Neuropsychopharmacology · 2023

DOI: 10.1093/ijnp/pyad053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2023. Verfasst von Ta-Chun Lin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Antipsychotic Agents, Clozapine, Schizophrenia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Some schizophrenia patients treated with clozapine experience an inadequate response and adherence problems. The purpose of this study was to compare time to rehospitalization within 6 months in schizophrenia patients discharged on 3 clozapine regimens. Additionally, the temporal trend of prescription rate in each group was also explored.

Methods

Schizophrenia patients discharged from the study hospital from January 1, 2006, to December 31, 2021, (n = 3271) were included in the analysis. The type of clozapine prescribed at discharge was divided into 3 groups: clozapine plus long-acting injectable antipsychotics (clozapine + LAIs), clozapine plus other oral antipsychotics (clozapine + OAPs), and clozapine monotherapy. Survival analysis was used to compare time to rehospitalization within 6 months after discharge among the 3 groups. The temporal trend in the prescription rate of each group was analyzed using the Cochran-Armitage Trend test.

Results

Patients discharged on clozapine + LAIs had a significantly longer time to rehospitalization than those on clozapine + OAPs or clozapine monotherapy. The prescription rates of clozapine + LAIs and clozapine + OAPs significantly increased over time, whereas the prescription rates of clozapine monotherapy significantly decreased.

Conclusions

Compared with the clozapine + OAPs group, the clozapine + LAIs group had a lower risk of rehospitalization and a lower dose of clozapine prescribed. Therefore, if a second antipsychotic is required for patients who are taking clozapine alone, LAIs should be considered earlier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsClozapineSchizophreniaHumansAdministration, OralDelayed-Action PreparationsHospitals, PsychiatricPatient DischargeTaiwan

Stichwörter der Autor:innen

Schizophreniaclozapinelong-acting injectable antipsychoticsrehospitalizationtemporal trend

Substanzen

Antipsychotic AgentsClozapineDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
  • Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Kaohsiung, Taiwan.
  • Department of Psychiatry, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.

Zitieren

APA

Lin, T. C., & Lin, C. H. (2023). Schizophrenia Patients Discharged on Clozapine Plus Long-Acting Injectable Antipsychotics From a Public Psychiatric Hospital in Taiwan, 2006–2021. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyad053

Vancouver

Lin TC, Lin CH. Schizophrenia Patients Discharged on Clozapine Plus Long-Acting Injectable Antipsychotics From a Public Psychiatric Hospital in Taiwan, 2006–2021. International Journal of Neuropsychopharmacology. 2023. doi:10.1093/ijnp/pyad053

BibTeX
@article{Lin2023,
  author = {Lin, Ta-Chun and Lin, Ching-Hua},
  title = {Schizophrenia Patients Discharged on Clozapine Plus Long-Acting Injectable Antipsychotics From a Public Psychiatric Hospital in Taiwan, 2006–2021},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2023},
  doi = {10.1093/ijnp/pyad053}
}
Kostenlos starten →